IDEXX Labs (IDXX) Tops Q3 EPS by 3c; Boosts FY12 EPS, Guides FY13 EPS, Revs
IDEXX Labs (NASDAQ: IDXX) reported Q3 EPS of $0.76, $0.03 better than the analyst estimate of $0.73. Revenue for the quarter came in at $315.5 million versus the consensus estimate of $318.55 million.
IDEXX Labs sees FY2012 EPS of $3.08-3.11, versus prior guidance of $3.05-3.10 and the consensus of $3.09. IDEXX Labs sees FY2012 revenue of $1.30 billion, versus prior guidance of $1.30-1.31 billion and the consensus of $1.31 billion.
IDEXX Labs sees FY2013 EPS of $3.37-3.47, versus the consensus of $3.45. IDEXX Labs sees FY2013 revenue of $1.405-1.425 billion, versus the consensus of $1.39 billion.
For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.
IDEXX Labs sees FY2012 EPS of $3.08-3.11, versus prior guidance of $3.05-3.10 and the consensus of $3.09. IDEXX Labs sees FY2012 revenue of $1.30 billion, versus prior guidance of $1.30-1.31 billion and the consensus of $1.31 billion.
IDEXX Labs sees FY2013 EPS of $3.37-3.47, versus the consensus of $3.45. IDEXX Labs sees FY2013 revenue of $1.405-1.425 billion, versus the consensus of $1.39 billion.
For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.